Example cases

Fixed, precomputed example consults. Pick a case, then run the engine to see its ranked output.
Run your own patient — sign in or request access
{{ selectedCaseLabel }}

Patient consult

Inputs of the selected example — read-only
PATIENT
DISEASE
TREATMENT HISTORY
Failed drug classes
Specific prior biologics / small molecules
SAFETY SCREEN
RENAL & HEPATIC
{{ f_egfr }}
JAK, MTX, cyclosporine and 5-ASA require eGFR ≥30
Child-Pugh
SEROLOGY & CONTEXT
Extraintestinal manifestations
CARDIAC
CHF (NYHA)
VIRAL & GENETICS
MALIGNANCY · SURGERY · TDM
PATIENT PREFERENCES
Preferred route
CASE RECAP
{{ lpReadiness }}
{{ lpDisease }} {{ lpDemo }} {{ fl.label }}
Run your own patient — sign in or request access
Clinical decision support for licensed physicians — does not replace clinical judgment. Demo build; no PHI stored.
ENGINE OUTPUT
{{ engineStatus }}
{{ validationTitle }}
{{ validationMessage }}
{{ validationDetail }}
CUSTOM PATIENTS
Custom patients are available to signed-in clinicians.
Run your own patient — sign in or request access
✓ {{ passedLabel }} ⏹ {{ passedLabel }} ! {{ w.code }}
SAFETY-GATED THERAPIES
{{ b.name }} {{ b.cls }} {{ b.reason }}
C. DIFFICILE — TREAT FIRST Initiate before or concurrently with IBD therapy — not after it
{{ a.name }} {{ a.dose }} {{ a.note }}
ECCO Infections 2026 Statement 22 · IDSA 2021 · DGVS 2025
ASUC RESCUE MODE {{ rescuePhaseLabel }}
{{ a.priority }} {{ a.title }}
{{ a.desc }} {{ a.rationale }} {{ a.guideline }}
ACG 2025 · AGA Inpatient 2025 · ECCO UC Medical 2026 p21 (rescue statement) · BSG IBD 2025 GPS 44 · DGVS S3 UC 2025 Empfehlung 2.22
{{ s.urgency }}
{{ s.name }} {{ s.cls }} · {{ s.dose }}
{{ s.just }} {{ s.warn }}
{{ h.name }}
{{ h.cls }}
{{ r.label }}
{{ c.v }}
Composite score and supporting attributes as delivered, compared across the top therapies in this batch.
Decision support for licensed clinicians — not a medical device. Synthetic or de-identified data only.
{{ r.rank }}
{{ r.name }} {{ r.cls }} AGA {{ r.tier }} EL {{ r.el }}
{{ r.dose }} · {{ r.route }}
GKV {{ r.costLine }}
{{ r.just }}
{{ r.scoreLine }}
⚠{{ r.flagText }}
Outcome simulator — sign in
{{ r.score }}
{{ metaLine }}
Rankings: output of the same engine pipeline as POST /v1/recommendation, computed once for this fixed example case — nothing on this page runs a patient you enter. Prices: GKV Lauer-Taxe 2025 (EUR).
⌁ Pick an example case and run the engine — therapies are gated, scored and ranked with citations.

Therapy catalog

{{ catalogCount }}
No active case. Run an example consult first — the therapies it ranks are listed here. Run a consult
{{ caseLine }}
Therapies ranked for the selected example consult.

{{ dName }}

{{ dSub }}
{{ s.h }}
{{ s.body }}

Explainability

No active case. The narrative explains the latest consult's ranking. Run a consult
{{ caseLine }}
CLINICAL NARRATIVE

{{ p.text }}

SCORE — TOP 3
{{ m.rank }} {{ m.name }} {{ m.score }}
{{ b.label }}
{{ b.val }}

Prior authorization

No active case. Prior-auth documentation is generated from a consult. Run a consult
Requesting:
CLINICAL JUSTIFICATION LETTER
{{ authLetter }}
Guideline concordance

Do the rankings agree with the guidelines?

For the current case, each ranked therapy is checked against the indexed adult societies (ECCO, ACG, AGA, DGVS, BSG). Concordance = the share of recommending societies behind each pick.

No active case. Concordance is computed on the latest consult's ranking. Run a consult
{{ caseLine }}
{{ ccTop3Pct }}
Top-3 guideline-concordant
{{ ccTopPick }}
Engine #1 pick
{{ ccAvg }}
Avg societies / therapy
{{ r.rank }}
{{ r.name }} {{ r.cls }}
{{ c.label }}
{{ r.pct }}
of 5 indexed
Endorsement = the society's guideline corpus indexes this therapy. ESPGHAN/NASPGHAN (pediatric) and PIANO (pregnancy registry) are out of scope for adult cases.

Clinician validation

{{ caseLine }}
Do you agree with the engine's #1 recommendation?
FEEDBACK LOG
{{ fbConcordance }}
No feedback recorded yet in this browser.
{{ f.verdict }} {{ f.text }} {{ f.when }}

Cohort analytics

Aggregated over consults run in this browser — no PHI leaves the device.
{{ s.value }}
{{ s.label }}
TOP-RANKED THERAPY DISTRIBUTION
Run consults to populate cohort analytics.
{{ b.name }}
{{ b.n }}
{{ infoEyebrow }}

{{ infoTitle }}

{{ infoBlurb }}

{{ infoExtra }}

Settings

Language
EN · DE
Local data
{{ localDataLine }}
About this build
{{ buildInfo }}